JP2006528171A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528171A5 JP2006528171A5 JP2006520920A JP2006520920A JP2006528171A5 JP 2006528171 A5 JP2006528171 A5 JP 2006528171A5 JP 2006520920 A JP2006520920 A JP 2006520920A JP 2006520920 A JP2006520920 A JP 2006520920A JP 2006528171 A5 JP2006528171 A5 JP 2006528171A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- group
- het
- vasopressin
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 C*(C)c1nnc(*)[n]1*(*)*** Chemical compound C*(C)c1nnc(*)[n]1*(*)*** 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0317227.7A GB0317227D0 (en) | 2003-07-23 | 2003-07-23 | Treatment of male sexual dysfunction |
| PCT/IB2004/002300 WO2005006899A1 (en) | 2003-07-23 | 2004-07-12 | Treatment of male sexual dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006528171A JP2006528171A (ja) | 2006-12-14 |
| JP2006528171A5 true JP2006528171A5 (enExample) | 2007-08-30 |
Family
ID=27772516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520920A Abandoned JP2006528171A (ja) | 2003-07-23 | 2004-07-12 | 男性機能障害の治療 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1656183B1 (enExample) |
| JP (1) | JP2006528171A (enExample) |
| AT (1) | ATE380048T1 (enExample) |
| BR (1) | BRPI0412255A (enExample) |
| CA (1) | CA2533177A1 (enExample) |
| CL (1) | CL2004001702A1 (enExample) |
| GB (1) | GB0317227D0 (enExample) |
| MX (1) | MXPA05014200A (enExample) |
| TW (1) | TW200510424A (enExample) |
| UA (1) | UA79674C2 (enExample) |
| WO (1) | WO2005006899A1 (enExample) |
| ZA (1) | ZA200505957B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1663978T3 (da) | 2003-07-23 | 2008-04-07 | Bayer Pharmaceuticals Corp | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser |
| GB0504556D0 (en) * | 2005-03-04 | 2005-04-13 | Pfizer Ltd | Novel pharmaceuticals |
| ES2313626T3 (es) * | 2005-03-21 | 2009-03-01 | Pfizer Limited | Derivados de triazol sustituidos como antagonistas de oxitocina. |
| US20220152032A1 (en) * | 2020-11-13 | 2022-05-19 | Pharma America Holding Inc. | Sexual therapy formulation and method of treatment |
| CN117414361A (zh) * | 2023-09-28 | 2024-01-19 | 华中农业大学 | 一种化合物在预防和治疗革兰氏阴性菌病方面的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2000223275A1 (en) * | 2000-02-08 | 2001-08-20 | Yamanouchi Pharmaceutical Co..Ltd. | Novel triazole derivatives |
| GB0224919D0 (en) * | 2002-10-25 | 2002-12-04 | Pfizer Ltd | Triazole compounds useful in therapy |
-
2003
- 2003-07-23 GB GBGB0317227.7A patent/GB0317227D0/en not_active Ceased
-
2004
- 2004-07-06 CL CL200401702A patent/CL2004001702A1/es unknown
- 2004-07-12 AT AT04743961T patent/ATE380048T1/de not_active IP Right Cessation
- 2004-07-12 MX MXPA05014200A patent/MXPA05014200A/es unknown
- 2004-07-12 CA CA002533177A patent/CA2533177A1/en not_active Abandoned
- 2004-07-12 WO PCT/IB2004/002300 patent/WO2005006899A1/en not_active Ceased
- 2004-07-12 JP JP2006520920A patent/JP2006528171A/ja not_active Abandoned
- 2004-07-12 BR BRPI0412255-0A patent/BRPI0412255A/pt not_active IP Right Cessation
- 2004-07-12 EP EP04743961A patent/EP1656183B1/en not_active Expired - Lifetime
- 2004-07-19 TW TW093121513A patent/TW200510424A/zh unknown
- 2004-09-02 UA UAA200508142A patent/UA79674C2/uk unknown
-
2005
- 2005-07-25 ZA ZA200505957A patent/ZA200505957B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3468972B1 (en) | Compounds and compositions for inhibiting the activity of shp2 | |
| EP3218378B1 (en) | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors | |
| AU2012327210B2 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| WO2019165073A1 (en) | Shp2 phosphatase inhibitors and methods of use thereof | |
| TWI556820B (zh) | Ｈｓｐ９０抑制劑之組合 | |
| RU2006108799A (ru) | N3-замещенные имидазопиридиновые ингибиторы c-kit | |
| JP2010513448A5 (enExample) | ||
| BR112021006905A2 (pt) | composto, sal e solvato do mesmo e agente agonístico de sting, composição farmacêutica que compreende o dito composto e uso do mesmo para suprimir a progressão de, suprimir a recorrência de e/ou tratar câncer ou doença infecciosa | |
| JP2004514718A5 (enExample) | ||
| JP2006513200A5 (enExample) | ||
| JP2018502853A (ja) | 炎症およびがんを処置するための複素環式ｉｔｋ阻害剤 | |
| ES2917526T3 (es) | Compuestos de aminonaptoquinona y composición farmacéutica para bloquear el sistema ubiquitinación-proteasoma en enfermedades | |
| RU2005122484A (ru) | Композиции, используемые в качестве ингибиторов протеинкиназ | |
| JP2008525417A5 (enExample) | ||
| JP2012500785A5 (enExample) | ||
| JP2009541223A5 (enExample) | ||
| JP2006524254A5 (enExample) | ||
| JP2017503815A (ja) | がんまたは炎症性疾患を処置するための置換されたピロロピリジンおよびピロロピラジン | |
| RU2007100134A (ru) | Пиразолпиримидины | |
| JP2005505618A5 (enExample) | ||
| JP2021501208A5 (enExample) | ||
| AU2016298962B2 (en) | Compounds and pharmaceutical composition associated with ubiquitination-proteasome system | |
| JP2013529619A (ja) | タンパク質キナーゼ阻害剤としてのヘテロアリール化合物および組成物 | |
| JP2010155827A5 (enExample) | ||
| CN1950376A (zh) | 莪术醇衍生物、含该衍生物的组合物及所述衍生物的制药用途 |